According to a new report, published by KBV research, The Global Genu Recurvatum Market size is expected to reach $8.72 billion by 2031, rising at a market growth of 5.3% CAGR during the forecast period.
The economic burden of musculoskeletal disorders has also prompted governments and healthcare organizations to prioritize research and development in orthopedic medicine. Chronic knee conditions, including genu recurvatum, contribute to reduced workforce productivity, higher disability rates, and increased healthcare expenditures.
The Surgical Treatments segment led the maximum revenue in the Global Genu Recurvatum Market by Treatment Type in 2023, thereby, achieving a market value of $4.8 billion by 2031. The growing number of cases of severe knee hyperextension is driving the surgical treatments segment. The structural deformities in these cases require corrective surgical procedures, including osteotomies, ligament reconstructions, and joint realignment surgeries.
The Hospitals segment is growing at a CAGR of 4.9 % during the forecast period. Hospitals are equipped with state-of-the-art surgical technologies, such as robotic-assisted knee correction, high-precision imaging, and minimally invasive surgical tools, which enhance treatment outcomes. Additionally, the availability of specialized orthopedic surgeons, access to emergency care, and better insurance coverage for surgical interventions contribute to the segment’s dominance.
Full Report: https://www.kbvresearch.com/genu-recurvatum-market/
The North America region dominated the Global Genu Recurvatum Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3.4 billion by 2031. The Europe region is anticipated to grow at a CAGR of 4.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 5.9% during (2024 - 2031).
By Treatment Type
By End User
Unique Offerings 
